JP2024506550A5 - - Google Patents

Info

Publication number
JP2024506550A5
JP2024506550A5 JP2023546197A JP2023546197A JP2024506550A5 JP 2024506550 A5 JP2024506550 A5 JP 2024506550A5 JP 2023546197 A JP2023546197 A JP 2023546197A JP 2023546197 A JP2023546197 A JP 2023546197A JP 2024506550 A5 JP2024506550 A5 JP 2024506550A5
Authority
JP
Japan
Prior art keywords
sequence
nucleic acid
polypeptide
sequences
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023546197A
Other languages
English (en)
Japanese (ja)
Other versions
JP7872275B2 (ja
JP2024506550A (ja
Filing date
Publication date
Priority claimed from GB2101228.1A external-priority patent/GB2603166A/en
Application filed filed Critical
Publication of JP2024506550A publication Critical patent/JP2024506550A/ja
Publication of JP2024506550A5 publication Critical patent/JP2024506550A5/ja
Application granted granted Critical
Publication of JP7872275B2 publication Critical patent/JP7872275B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023546197A 2021-01-29 2022-01-28 治療剤及び診断剤並びにその使用 Active JP7872275B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2101228.1 2021-01-29
GB2101228.1A GB2603166A (en) 2021-01-29 2021-01-29 Therapeutic and Diagnostic Agents and Uses Thereof
PCT/EP2022/052130 WO2022162192A2 (en) 2021-01-29 2022-01-28 Therapeutic and diagnostic agents and uses thereof

Publications (3)

Publication Number Publication Date
JP2024506550A JP2024506550A (ja) 2024-02-14
JP2024506550A5 true JP2024506550A5 (cg-RX-API-DMAC7.html) 2025-01-27
JP7872275B2 JP7872275B2 (ja) 2026-06-09

Family

ID=74865391

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023546197A Active JP7872275B2 (ja) 2021-01-29 2022-01-28 治療剤及び診断剤並びにその使用

Country Status (16)

Country Link
US (1) US20240199724A1 (cg-RX-API-DMAC7.html)
EP (1) EP4232057A2 (cg-RX-API-DMAC7.html)
JP (1) JP7872275B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230150813A (cg-RX-API-DMAC7.html)
CN (1) CN116847864A (cg-RX-API-DMAC7.html)
AU (1) AU2022213494A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023015191A2 (cg-RX-API-DMAC7.html)
CA (1) CA3205854A1 (cg-RX-API-DMAC7.html)
CL (1) CL2023002234A1 (cg-RX-API-DMAC7.html)
CO (1) CO2023010063A2 (cg-RX-API-DMAC7.html)
GB (1) GB2603166A (cg-RX-API-DMAC7.html)
IL (1) IL304734B2 (cg-RX-API-DMAC7.html)
MX (1) MX2023008886A (cg-RX-API-DMAC7.html)
PE (1) PE20250016A1 (cg-RX-API-DMAC7.html)
TW (1) TW202246304A (cg-RX-API-DMAC7.html)
WO (1) WO2022162192A2 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12037382B2 (en) * 2018-02-05 2024-07-16 Stichting Vu Inverse agonistic anti-US28 antibodies
KR20230092863A (ko) 2020-06-11 2023-06-26 프로벤션 바이오, 인코포레이티드 제1형 당뇨병을 예방하기 위한 방법 및 조성물
MX2023013851A (es) 2021-05-24 2023-12-08 Provention Bio Inc Metodos para el tratamiento de diabetes tipo 1.
GB202201137D0 (en) * 2022-01-28 2022-03-16 Thelper As Therapeutic and diagnostic agents and uses thereof
CN115947869B (zh) * 2022-11-28 2023-12-12 广州佰芮慷生物科技有限公司 一种靶向人巨细胞病毒的嵌合抗原受体、car-nk细胞及用途

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US541A (en) 1837-12-26 Daniel desmond
US5874A (en) 1848-10-24 Apparatus eob baking- water
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4957939A (en) 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
US4472509A (en) 1982-06-07 1984-09-18 Gansow Otto A Metal chelate conjugated monoclonal antibodies
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
SE459005B (sv) 1985-07-12 1989-05-29 Aake Rikard Lindahl Saett att framstaella sfaeriska polymerpartiklar
US4938948A (en) 1985-10-07 1990-07-03 Cetus Corporation Method for imaging breast tumors using labeled monoclonal anti-human breast cancer antibodies
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5824311A (en) 1987-11-30 1998-10-20 Trustees Of The University Of Pennsylvania Treatment of tumors with monoclonal antibodies against oncogene antigens
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
US5585362A (en) 1989-08-22 1996-12-17 The Regents Of The University Of Michigan Adenovirus vectors for gene therapy
JPH049249A (ja) 1990-04-27 1992-01-14 Kusuda:Kk 塗型剤吹き付け機
US6005079A (en) 1992-08-21 1999-12-21 Vrije Universiteit Brussels Immunoglobulins devoid of light chains
DE69334275D1 (de) 1992-08-21 2009-05-20 Univ Bruxelles Immunoglobuline ohne Leichtkette
US6765087B1 (en) 1992-08-21 2004-07-20 Vrije Universiteit Brussel Immunoglobulins devoid of light chains
US5350674A (en) 1992-09-04 1994-09-27 Becton, Dickinson And Company Intrinsic factor - horse peroxidase conjugates and a method for increasing the stability thereof
US5846945A (en) 1993-02-16 1998-12-08 Onyx Pharmaceuticals, Inc. Cytopathic viruses for therapy and prophylaxis of neoplasia
US5801005A (en) 1993-03-17 1998-09-01 University Of Washington Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
GB9506466D0 (en) 1994-08-26 1995-05-17 Prolifix Ltd Cell cycle regulated repressor and dna element
CA2192782C (en) 1995-12-15 2008-10-14 Nobuyuki Takechi Production of microspheres
US5716081A (en) 1996-03-11 1998-02-10 Automotive Products (Usa), Inc. Spring clip for quick connect coupling
US5739169A (en) 1996-05-31 1998-04-14 Procept, Incorporated Aromatic compounds for inhibiting immune response
ATE374248T1 (de) 1996-06-27 2007-10-15 Vlaams Interuniv Inst Biotech Antikörpermoleküle, die spezifisch mit dem aktiven zentrum oder dem aktiven spalt eines zielmoleküls interagieren
GB9701425D0 (en) 1997-01-24 1997-03-12 Bioinvent Int Ab A method for in vitro molecular evolution of protein function
EP1235842A4 (en) 1999-10-15 2003-04-23 Univ Massachusetts Rna interference pathway genes as tools for targeted genetic interference
US6326193B1 (en) 1999-11-05 2001-12-04 Cambria Biosciences, Llc Insect control agent
WO2001096584A2 (en) 2000-06-12 2001-12-20 Akkadix Corporation Materials and methods for the control of nematodes
US7025968B2 (en) * 2000-08-30 2006-04-11 Chemocentryx, Inc. CMV vaccines
CA2728739C (en) * 2008-06-20 2017-07-11 Duke University Use of human cytomegalovirus antigens to enhance immune responses to cancer cells
LT2691417T (lt) 2011-03-29 2018-10-25 Roche Glycart Ag Antikūno fc variantai
US12037382B2 (en) * 2018-02-05 2024-07-16 Stichting Vu Inverse agonistic anti-US28 antibodies
WO2021008840A1 (en) 2019-07-12 2021-01-21 Københavns Universitet Fusion toxin proteins for treatment of diseases related to cmv infections
US20220324947A1 (en) * 2019-08-05 2022-10-13 Stichting Vu Identification and Elimination of HCMV-Infected Cells
GB2595299B (en) 2020-05-21 2022-08-03 Mabsolve Ltd Modified immunoglobulin FC regions

Similar Documents

Publication Publication Date Title
AU2015265870B2 (en) PD-L1 antibodies and uses thereof
CN109310764B (zh) 高亲和力b7-h6抗体和抗体片段
KR102602137B1 (ko) Tim-4 길항제 및 pd-1 길항제의 조합물 및 사용 방법
JP2023524102A5 (cg-RX-API-DMAC7.html)
JP2022531242A (ja) 抗hvem抗体およびそれらの使用
JP2019515648A5 (cg-RX-API-DMAC7.html)
IL304734B1 (en) Therapeutic and diagnostic materials and their uses
US20240383993A1 (en) Anti-4-1bb nanobodies
CN103717620A (zh) 用于检测和诊断癌症的抗体i-3859的用途
CN115461371A (zh) 靶向ox40的抗体及其制备方法和应用
KR20220139245A (ko) Gucy2c 결합 폴리펩타이드 및 그의 용도
JP2023515875A (ja) 抗cd123抗体またはキメラ抗原受容体(car)に結合する抗イディオタイプ抗体、およびそれを使用する方法
WO2023061421A1 (en) Single-domain 4-1bb antibodies
CN119677777A (zh) 抗cd28抗体
CN116444672A (zh) 人表皮生长因子3的抗体、其制备方法及其应用
WO2002055089A9 (en) Immunoassay technique using multispecific molecules
WO2023056927A1 (en) Anti-amhrii antibodies
WO2024196877A1 (en) Rabbit monoclonal antibodies targeting acute myeloid leukemia antigens
HK40108650A (en) Single-domain 4-1bb antibodies
AU2021385609A1 (en) Precise labeling of protein scaffolds with cargo for use in biomedical applications
CN117836325A (zh) 一种抗tnfr2抗体及其制备方法和应用
CN119060182A (zh) 一种抗ceacam5的抗体及其用途
Atreya et al. Future trends in confocal laser endomicroscopy: Improved imaging quality and immunoendoscopy
HK40004147A (en) High affinity b7-h6 antibodies and antibody fragments
HK40073393A (en) Bispecific antibody and use thereof